One day. One community. Infinite hope.
One day. One community. Infinite hope.
Be part of history. Families, researchers, and advocates are coming together for the future of SLC6A1
SLC6A1 Europe, Research and Support Alliance, Inaugural Scientific Symposium and Family Conference will take place 28-29 August 2025 in Lisbon, Portugal, ahead of the International League Against Epilepsy Congress.
Located at Vila Gale Opera Hotel, the Alliance is hosting a relaxed family bonding day on Thursday 28th August. A unique opportunity to meet other families with loved ones affected by SLC6A1 gene mutation, share experiences, learn from each other, and build lasting relationships with a group of people who truly understand your experience. Families are welcome to bring their SLC6A1 loved ones with them for this special two day event.
Friday 29th August will see in the inaugural European scientific symposium. This event offers two conference rooms, a scientific room and a family room. Both rooms will present the very best research and development relating to SLC6A1. With international speakers from across the globe presenting their existing successes, current projects, and project proposals, with a particular focus on showcasing work being done across Europe to move the scientific needle towards translational therapies for SLC6A1. As an alliance of motivated patient advocates, researchers and partners, we create opportunities for collaboration, and knowledge sharing, fostering creative partnerships that will result in scientific advances that change the lives of those diagnosed with SLC6A1. The family room will be presented with the information in a more accessible way. A respite room will be available for families to take a break if needed. Families with and without children present can utilise this space.
Lunch will be included, as well as coffee breaks and pastries. A Rare Reception will be hosted on Friday 29th from 5pm, offering a chance to network, circulate, and make friends.
Creation of the SLC6A1 European Alliance : We are creating an alliance that will serve as an umbrela organisation of various associations established across Europe for the SLC6A1 gene mutation.
Global SLC6A1 Census.
In alicante skin or teeth tissues are being used to generate neurons for studying drug efficacy in SLC6A1
A study on the microbiome’s role in SLC6A1 could offer insights into personalised treatments.
Establishment of a European biorepository, that will enable us to collect and manage biological samples.
Two centers of Excelence dedicated to advancing research and treatment for SLC6A1 related disorders: one in Barcelona and one in Denmark. These centers will serve as hubs for research, clinical trials, and patient care.
A laboratory in Verona, under the direction of Professor Andrea Vettori, uses SLC6A1 knock-out zebrafish to test molecules with phenylbutyrate similar properties.
En Varese, en la Universidad Insubria, la profesora Elena Bossi centra su investigación en los ovocitos de Xenopus laevis que expresan RGAT1